抗生物質のより保守的な使用は,小児の肺炎における治療結果に悪影響を及ぼさない
Lena Boeger1, Nina Volkmann2, Jeanette Probst2
1Clinic for Horses, University of Veterinary Medicine Hannover, Foundation, Germany.
Veterinary journal (London, England : 1997)
|February 21, 2026
まとめ
フォール・ブロンコ肺炎の抗菌剤治療を遅らせることで,抗生物質の使用が著しく減少しました. このアプローチは,比較可能な治療成功率,死亡率,再発率を維持し,獣医学における抗菌剤耐性に関する懸念に対処しました.
科学分野:
- 獣医医学 獣医医学は,獣医医学というものです.
- エクイネヘルス ( Equine Health) とは
- 薬理学 薬理学とは
背景:
- 抗菌剤耐性は,獣医学における懸念が高まっています.
- スクリーニングプログラムによる小児ブロンコ肺炎の早期診断は,抗生物質の使用量の増加につながる可能性があります.
- サブクリニカルな肺炎を患った多くの小山羊は自発的に回復し,より賢明な抗生物質戦略への関心を誘発します.
研究 の 目的:
- フォール・ブロンコ肺炎に対する抗菌薬療法の遅延が,全般的な抗生物質消費量を減少させるかどうかを評価する.
- 治療戦略の遅延が子犬の状態の解決に効果があるかどうかを評価する.
- 治療の遅延が治療失敗,再発,死亡率に与える影響を判断する.
主な方法:
- ブロンコ肺炎と診断された1200匹の温血小羊のコホート研究が行われました.
- 仔牛は毎週臨床検査,血液検査,超音波検査を受けていました.
- 治療は,のスコアの増加に基づいて開始され,値は時間とともに調整されました (15.0cmから20.0cm).
主要な成果:
- 治療の値の調整後,治療を受けた子羊の割合は29.0%から17.5%に減少した.
- 死亡率は治療群全体で1.0%で安定した.
- 治療失敗 (2.8% vs. 8.6%) や再発 (2.3% vs. 0.95%) の割合において,早期治療群と後期治療群の間で有意な差異は観察されなかった.
結論:
- フォール・ブロンコ肺炎の抗菌剤治療を,より高度な病変が現れるまで延期することは,抗生物質を必要とするフォールの数を大幅に減少させます.
- 抗菌剤の使用に対するこの保守的なアプローチは,治療の成功を損なわないし,失敗,再発,死亡率も同様である.
- この発見は,抗菌剤耐性に対抗するために,馬獣医学においてより制限的な抗生物質の使用を支持する.
キーワード:
ロドコッカス・エクイ (Rhodococcus equi) とはStreptococcus equi亜種 ゾオエピデミカス (zooepidemicus) について抗微生物剤による処置bronchopneumonia ブロンコプネウモニア ブロンコプネウモニアフォールズ フォールズ胸部超音波検査についてさらに関連する動画
関連する概念動画
Pneumonia IV: Management
852
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
852
Antimicrobial Effectiveness
1.1K
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
1.1K
COPD: Management Using Bronchodilators and Corticosteroids
904
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
904
Pneumonia V: Nursing management and Prevention
3.7K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.7K
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
1.5K
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.5K
Antibiotic Selection
60.5K
Overview
60.5K


